Commentary, Int J Cardiovasc Res Vol: 3 Issue: 1
Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study
| Hisato TakagiM* and Takuya Umemoto |
| Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan |
| Corresponding author : Hisato Takagi Department of Cardiovascular Surgery, Shizuoka Medical Center, 762-1 Nagasawa, Shimizu-cho, Sunto-gun, Shizuoka 411-8611, Japan Tel: +81-55-975-2000; Fax: +81-55-975-2725 E-mail: [email protected] |
| Received: December 26, 2013 Accepted: February 20, 2014 Published: February 28, 2014 |
| Citation: Takagi H, Umemoto T (2014) Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study. Int J Cardiovasc Res 3:1. doi:10.4172/2324-8602.1000156 |
Abstract
Specificity of the Cardiocerebral-Event Reductions in the Kyoto Heart and Jikei Heart Study
The Kyoto Heart Study was a prospective randomized open blinded end-point (PROBE)-design trial, in which 3031 Japanese patients (mean, 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-angiotensin receptor blocker (ARB) treatment.
